Ask AI
ProCE Banner Series

Critical Conversations in AML: Exploring Evidence-Based Maintenance Strategies 

Join us online for this interactive roundtable webinar featuring expert faculty discussing the latest data on new and emerging AML maintenance therapies. Register now!

To Register: Please click the green “Learn More” button below. On the next page, select Register for Virtual Event. Once registered, you will receive a confirmation email. Follow-up emails with event details will be sent as the event nears.

  AMA
Who Should Attend

This program is intended for hematologists/oncologists and other multidisciplinary care team members who treat patients with AML.

All Events

Critical Conversations in AML: Exploring Evidence-Based Maintenance Strategies

Past Events

June

04

2023

6:30 AM - 7:30 AM Central Time (CT)

Virtual

Topics

  • Welcome and Introductions
  • Discussion: Post-chemotherapy Maintenance Therapy
  • Discussion: Post-transplant Maintenance Therapy
  • Discussion: Maintenance Therapy Options on the Horizon
  • Highlights of Key AML Abstracts at ASCO 2023
  • Audience Question and Answer

Additional Info

There are no fees required to participate in this activity.

Americans With Disabilities Act
Event staff will be glad to assist you with any special needs (eg, physical, dietary). Please contact meetings@clinicaloptions.com prior to the live event.

CME/CE Info

Goal Statement
This program aims to improve learners’ knowledge, confidence, and competence in integrating the latest clinical guidance and expert recommendations on the role of maintenance therapy in the long-term management of AML into clinal practice. 

Target Audience
This program is intended for hematologists/oncologists and other multidisciplinary care team members who treat patients with AML. 

Learning Objectives
Upon completion of this activity, participants should be able to:

  • Characterize the AML patient profile identifying those at risk for early relapse and who may benefit from maintenance therapy
  • Select optimal maintenance strategies in AML based on the latest clinical evidence and expert guidance to improve patient outcomes
  • Implement evidence-based interventions to manage treatment-related adverse events
  • Formulate collaborative strategies and shared decision-making practices to ensure patient engagement in treatment decisions
  • Identify all patients, regardless of race, age, or gender, with AML who would likely benefit from treatment or enrollment on a clinical trial

Accreditation

Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education

CCO designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure of Conflicts of Interest 
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

Acknowledgement

Provided by Clinical Care Options, LLC.

Supported by an educational grant from Bristol Myers Squibb.

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address:

 

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191